GO:0004674 protein serine/threonine kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004674 describes the catalytic activity of enzymes that transfer the gamma-phosphate of ATP to serine or threonine residues on protein substrates, producing ADP and phosphoserine/phosphothreonine.
• This activity is central to signal transduction, cell cycle control, apoptosis, and metabolic regulation, and is conserved from yeast to humans.
• Dysregulation of serine/threonine kinases is implicated in cancer, cardiovascular disease, neurodegeneration, and metabolic disorders.
• Key experimental models include CRISPR knockout, point-mutation knock-in, and overexpression cell lines to dissect kinase function and substrate specificity.
• Modern methods such as phosphoproteomics, Ribo-seq, and CRISPR library screening enable systematic mapping of kinase signaling networks.
• EDITGENE provides custom CRISPR cell model generation and bioinformatics services to accelerate kinase research.
Description
Protein serine/threonine kinases (PS/TKs) constitute one of the largest families of enzymes in eukaryotes, catalyzing the phosphorylation of serine and threonine residues on target proteins. This post-translational modification acts as a molecular switch that regulates protein activity, localization, stability, and interactions, thereby controlling virtually every cellular process. The Gene Ontology term GO:0004674, protein serine/threonine kinase activity, captures this essential catalytic function and is a cornerstone of signal transduction research. Researchers study PS/TKs to understand how cells respond to external cues, maintain homeostasis, and execute developmental programs. Dysregulation of these kinases is linked to a wide range of diseases, including cancer, diabetes, and neurodegenerative disorders, making them prime therapeutic targets. The availability of precise genetic models and high-throughput screening tools has accelerated the functional annotation of these enzymes. This article provides a comprehensive overview of GO:0004674, covering its definition, biological significance, key genes, regulatory mechanisms, disease associations, and state-of-the-art research methodologies. By integrating authoritative QuickGO data with verified PubMed literature, we aim to support researchers in designing robust experiments and interpreting kinase biology.
protein serine/threonine kinase activity At A Glance
| GO ID | GO:0004674 |
|---|---|
| GO term | protein serine/threonine kinase activity |
| Ontology | molecular_function |
| Synonym | protein serine kinase activity; protein-serine kinase activity; protein serine-threonine kinase activity; protein threonine kinase activity; serine kinase activity; serine protein kinase activity; serine-specific protein kinase activity; serine(threonine) protein kinase activity; serine/threonine protein kinase activity; threonine-specific protein kinase activity |
| Major function | Catalyzes phosphorylation of serine and threonine residues on protein substrates using ATP as phosphate donor. |
| EC number | 2.7.11.1 (protein-serine/threonine kinase) |
| Cofactors | Mg2+ or Mn2+ typically required for ATP binding and catalysis. |
| Subcellular location | Cytoplasm, nucleus, mitochondria, membrane-associated, depending on the specific kinase. |
| Representative genes | PRKAA1, PRKAA2, WNK1, HIPK2, PIM1, AKT1, MAPK1, CDK1, etc.. |
What Is GO:0004674?
GO:0004674, protein serine/threonine kinase activity, is defined as the catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. In other words, it is the enzymatic activity that transfers a phosphate group from ATP to the hydroxyl group of serine or threonine residues on protein substrates, resulting in the formation of phosphoserine or phosphothreonine and ADP. This activity is a molecular function that enables cells to propagate signals, regulate enzyme activity, and control protein-protein interactions.
Why Is protein serine/threonine kinase activity Important in Cell Biology?
Protein serine/threonine kinase activity is fundamental to cellular signal transduction, controlling processes such as cell growth, proliferation, differentiation, apoptosis, and metabolism. Because these kinases are frequently mutated or dysregulated in human diseases, they represent major drug targets and biomarkers. Understanding their function through genetic and biochemical approaches is essential for both basic biology and translational medicine.
• Regulates cell cycle progression and checkpoint control.
• Mediates stress responses and apoptosis through phosphorylation cascades.
• Controls metabolic homeostasis via AMPK and related kinases.
• Modulates cardiovascular function and exercise adaptation.
• Involved in neuronal signaling and synaptic plasticity.
• Frequently mutated in cancers, driving oncogenic signaling.
• Target of many approved and investigational drugs (e.g., kinase inhibitors).
• Essential for immune cell activation and inflammatory responses.
• Plays a role in aging and geroprotection pathways.
• Enables high-throughput functional genomics via CRISPR screens.
What Happens During protein serine/threonine kinase activity?
Substrate recognition and binding
In simple terms: The kinase first grabs its target protein and the energy molecule ATP.
Serine/threonine kinases recognize specific consensus sequences around the target serine or threonine residue, often mediated by docking motifs or adaptor proteins. For example, murine protein serine-threonine kinase 38 (PSTK38) phosphorylates p53 at Ser15, a key event in DNA damage response. Similarly, WNK1 activation through Piezo1 involves phosphorylation of downstream targets.
ATP binding and phosphate transfer
In simple terms: The kinase uses ATP to attach a phosphate group onto the target protein.
The catalytic domain of the kinase binds ATP in a cleft between the N- and C-terminal lobes, coordinated by Mg2+ ions. The gamma-phosphate of ATP is transferred to the hydroxyl group of the serine or threonine residue, forming a phosphoester bond and releasing ADP. This reaction is highly conserved across all protein kinases.
Conformational change and product release
In simple terms: After phosphorylation, the kinase changes shape and releases the modified protein.
Phosphorylation induces conformational changes in the substrate that can alter its activity, localization, or interactions. The kinase then releases ADP and the phosphorylated substrate, ready for another catalytic cycle. For instance, PSTK38-mediated phosphorylation of ASK1 at Thr838 activates the ASK1-MKK4/7-JNK apoptotic pathway.
Signal amplification and crosstalk
In simple terms: One kinase can activate many downstream targets, creating a signaling cascade.
Serine/threonine kinases often function in cascades where one kinase phosphorylates and activates another, leading to signal amplification. For example, AMP-activated protein kinase (AMPK) phosphorylates multiple metabolic enzymes to maintain energy balance. Crosstalk between kinases ensures integrated cellular responses.
Key Genes Involved in GO:0004674 protein serine/threonine kinase activity
The following table lists representative genes encoding protein serine/threonine kinases, their major roles, and relevance to research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRKAA1 | Catalytic subunit of AMPK, regulates energy metabolism | Metabolic disorders, exercise mimetics |
| PRKAA2 | Catalytic subunit of AMPK, regulates energy metabolism | Diabetes, obesity |
| WNK1 | Regulates ion transport and cell volume | Hypertension, Piezo1 signaling |
| HIPK2 | Homeodomain-interacting protein kinase, stress response | Myocardial infarction, exercise adaptation |
| PSTK38 (STK38) | Activates p53 and ASK1 | Apoptosis, cancer |
| CPG16 | Downstream of cAMP-dependent protein kinase | Neuronal signaling |
| AKT1 | Serine/threonine kinase in PI3K pathway | Cancer, metabolism |
| MAPK1 (ERK2) | Mitogen-activated protein kinase | Proliferation, differentiation |
| CDK1 | Cyclin-dependent kinase 1 | Cell cycle regulation |
| PIM1 | Proto-oncogene serine/threonine kinase | Cancer, apoptosis |
| STK11 (LKB1) | Master kinase activating AMPK | Cancer, metabolism |
| CAMK2A | Calcium/calmodulin-dependent protein kinase II | Synaptic plasticity |
| RPS6KB1 | Ribosomal protein S6 kinase | Translation, cell growth |
| PRKACA | cAMP-dependent protein kinase catalytic subunit | Hormone signaling |
| CHEK1 | Checkpoint kinase 1 | DNA damage response |
| AURKA | Aurora kinase A | Mitosis, cancer |
| PLK1 | Polo-like kinase 1 | Mitosis, cancer |
| TBK1 | TANK-binding kinase 1 | Innate immunity |
How Is protein serine/threonine kinase activity Regulated?
Protein serine/threonine kinase activity is tightly regulated at multiple levels. Autophosphorylation or phosphorylation by upstream kinases can activate or inhibit catalytic activity. For example, AMPK is activated by LKB1-mediated phosphorylation under low-energy conditions. Protein phosphatases reverse phosphorylation, providing dynamic control. Subcellular localization, scaffold proteins, and second messengers such as cAMP and calcium further modulate kinase function. Dysregulation of these regulatory mechanisms contributes to disease pathogenesis.
protein serine/threonine kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AKT1 | Cancer, metabolic syndrome | Knockout and point-mutation cell lines |
| STK11 | Peutz-Jeghers syndrome, cancer | Knockout mouse models |
| WNK1 | Hypertension | Knock-in mice for gain-of-function |
| HIPK2 | Myocardial infarction | Cardiomyocyte-specific knockout |
| PSTK38 | Cancer, apoptosis | Overexpression and knockout cell lines |
Cancer
Many serine/threonine kinases are oncogenes or tumor suppressors. For instance, AKT1 promotes survival signaling, while STK11 (LKB1) acts as a tumor suppressor. PSTK38-mediated phosphorylation of p53 at Ser15 is critical for DNA damage-induced apoptosis, and its dysregulation can lead to chemoresistance. HIPK2 downregulation is associated with myocardial infarction and may influence cancer progression.
Cardiovascular disease
WNK1 signaling through Piezo1 regulates vascular tone and blood pressure. Exercise-induced downregulation of HIPK2 protects against myocardial infarction, highlighting the role of serine/threonine kinases in cardiac stress responses. AMPK activation improves cardiac function in metabolic disorders.
Metabolic disorders
AMPK is a master regulator of energy homeostasis, and its dysfunction is linked to type 2 diabetes and obesity. Betaine, an exercise mimetic, modulates kinase signaling for geroprotection. Targeting AMPK and related kinases is a promising therapeutic strategy.
Neurological disorders
CPG16, a serine/threonine kinase downstream of cAMP-dependent protein kinase, is implicated in neuronal signaling and may play a role in synaptic plasticity and neurodegenerative diseases. Calcium/calmodulin-dependent kinases are essential for memory formation.
From protein serine/threonine kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of kinase X affect cell proliferation? | CRISPR knockout cell line |
| Does a specific phosphorylation site mediate function? | Point-mutation knock-in (e.g., S15A) |
| Can a disease-associated mutation drive oncogenesis? | Knock-in of mutant allele |
| Where is the kinase localized in live cells? | Tagged knock-in (e.g., GFP) |
| Does overexpression of kinase X transform cells? | Doxycycline-inducible overexpression |
| Which pathways are regulated by kinase X? | CRISPR library screening |
How to Study the protein serine/threonine kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics | Global phosphorylation sites | Identify kinase substrates |
| CRISPR knockout screening | Gene essentiality and drug resistance | Discover synthetic lethal targets |
| Ribo-seq | Translation efficiency | Assess kinase impact on protein synthesis |
| RNA-seq | Transcript abundance | Measure transcriptional responses |
| Western blot | Protein expression and phosphorylation | Validate specific phosphorylation events |
| Immunoprecipitation | Protein-protein interactions | Identify kinase complexes |
| Live-cell imaging | Kinase activity dynamics | Monitor signaling in real time |
Phosphoproteomics
Mass spectrometry-based phosphoproteomics enables global identification of serine/threonine phosphorylation sites and quantification of changes upon kinase perturbation. This method is essential for mapping kinase-substrate networks and identifying downstream effectors.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that modulate kinase activity or confer resistance to kinase inhibitors. These screens are powerful for discovering synthetic lethal interactions and drug targets.
Ribo-seq and RNA-seq
Ribosome profiling (Ribo-seq) measures translation efficiency, while RNA-seq quantifies transcript levels. Both are used to assess how kinase signaling rewires gene expression programs.
Imaging and biosensors
Fluorescent biosensors and live-cell imaging allow real-time monitoring of kinase activity and localization. For example, FRET-based reporters can detect AMPK activation in single cells.
How CRISPR Can Be Used to Study GO:0004674 protein serine/threonine kinase activity
Knockout
CRISPR knockout of a serine/threonine kinase gene eliminates its catalytic activity, enabling loss-of-function studies. For example, knocking out PRKAA1 in cell lines abolishes AMPK signaling and alters metabolic responses. Knockout models are essential for validating kinase function in disease pathways.
Point Mutation
Point mutations can be introduced to ablate catalytic activity (e.g., K48R in AMPK) or to mimic phosphorylation (e.g., S15D in p53). These models help dissect the specific contribution of individual phosphorylation sites.
Knock-in
Knock-in of disease-associated mutations or tagged versions (e.g., GFP) allows precise tracking of kinase localization and function. For instance, knock-in of WNK1 mutants can model hypertension. Tagged knock-in lines are valuable for imaging and proteomics.
Overexpression
Overexpression of a wild-type or constitutively active kinase can reveal gain-of-function phenotypes, such as oncogenic transformation. Inducible systems provide temporal control. Overexpression is often used to study kinase substrates and downstream signaling.
How EDITGENE Supports protein serine/threonine kinase activity Research
Researchers studying protein serine/threonine kinase activity-related genes often need to determine whether a candidate gene is causally involved in a specific cellular process or disease. EDITGENE provides end-to-end CRISPR cell model services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for protein serine/threonine kinase activity research.
Frequently Asked Questions About protein serine/threonine kinase activity
What is protein serine/threonine kinase activity?
It is the enzymatic activity that transfers a phosphate group from ATP to serine or threonine residues on protein substrates, as defined by GO:0004674.
What genes are involved in protein serine/threonine kinase activity?
Genes include PRKAA1, PRKAA2, WNK1, HIPK2, PSTK38, AKT1, MAPK1, CDK1, and many others.
How is protein serine/threonine kinase activity regulated?
It is regulated by phosphorylation, autophosphorylation, phosphatases, second messengers, and subcellular localization.
What diseases are associated with serine/threonine kinases?
Cancer, cardiovascular disease, metabolic disorders, and neurological disorders are linked to dysregulated kinase activity.
What methods are used to study serine/threonine kinases?
Phosphoproteomics, CRISPR screening, Ribo-seq, RNA-seq, Western blot, and live-cell imaging are commonly used.
Can CRISPR be used to study kinase function?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect kinase biology.
What is the role of AMPK in metabolism?
AMPK is a serine/threonine kinase that acts as an energy sensor and regulates metabolic homeostasis.
How does PSTK38 regulate p53?
PSTK38 phosphorylates p53 at Ser15, activating p53 function in response to DNA damage.
What is the connection between WNK1 and Piezo1?
Piezo1 activation triggers WNK1 signaling, which regulates ion transport and cell volume.
How does exercise affect serine/threonine kinases?
Exercise modulates kinases such as HIPK2 and AMPK, influencing cardiovascular protection and metabolism.
Conclusion
GO:0004674 protein serine/threonine kinase activity is a fundamental molecular function that governs diverse cellular processes and is implicated in numerous human diseases. Understanding its mechanisms, key genes, and regulatory networks is essential for both basic research and therapeutic development. By leveraging advanced CRISPR models and high-throughput methods, researchers can accelerate the functional annotation of these kinases and identify novel drug targets. EDITGENE stands ready to support these efforts with customized cell models and bioinformatics solutions.
References
- 1. Geng L et al.. 2025. Systematic profiling reveals betaine as an exercise mimetic for geroprotection.. Cell 188(19):5403-5425.e33 PMID: 40570836
- 2. Jung JU et al.. 2025. Activation of WNK1 signaling through Piezo1.. Proc Natl Acad Sci U S A 122(35):e2513155122 PMID: 40880539
- 3. Seong HA et al.. 2012. Murine protein serine-threonine kinase 38 activates p53 function through Ser15 phosphorylation.. J Biol Chem 287(25):20797-810 PMID: 22532570
- 4. Kusić D et al.. 2020. Striated muscle-specific serine/threonine-protein kinase beta segregates with high versus low responsiveness to endurance exercise training.. Physiol Genomics 52(1):35-46 PMID: 31790338
- 5. Silverman MA et al.. 1999. CPG16, a novel protein serine/threonine kinase downstream of cAMP-dependent protein kinase.. J Biol Chem 274(5):2631-6 PMID: 9915791
- 6. Jung H et al.. 2008. Murine protein serine/threonine kinase 38 activates apoptosis signal-regulating kinase 1 via Thr 838 phosphorylation.. J Biol Chem 283(50):34541-53 PMID: 18948261
- 7. Zhou Q et al.. 2021. Exercise downregulates HIPK2 and HIPK2 inhibition protects against myocardial infarction.. EBioMedicine 74:103713 PMID: 34837851
- 8. Viollet B et al.. 2011. AMP-activated protein kinase and metabolic control.. Handb Exp Pharmacol PMID: 21484577
